首页> 美国卫生研究院文献>Cells >Intrinsically Disordered SRC-3/AIB1 Protein Undergoes Homeostatic Nuclear Extrusion by Nuclear Budding While Ectopic Expression Induces Nucleophagy
【2h】

Intrinsically Disordered SRC-3/AIB1 Protein Undergoes Homeostatic Nuclear Extrusion by Nuclear Budding While Ectopic Expression Induces Nucleophagy

机译:本质上无序的SRC-3 / AIB1蛋白通过异位表达诱导核吞噬作用而通过核芽进行稳态核挤压。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

SRC-3/AIB1 (Amplified in Breast Cancer-1) is a nuclear receptor coactivator for the estrogen receptor in breast cancer cells. It is also an intrinsically disordered protein when not engaged with transcriptional binding partners and degraded upon transcriptional coactivation. Given the amplified expression of SRC-3 in breast cancers, the objective of this study was to determine how increasing SRC-3 protein levels are regulated in MCF-7 breast cancer cells. We found that endogenous SRC-3 was expelled from the nucleus in vesicle-like spheres under normal growth conditions suggesting that this form of nuclear exclusion of SRC-3 is a homeostatic mechanism for regulating nuclear SRC-3 protein. Only SRC-3 not associated with CREB-binding protein (CBP) was extruded from the nucleus. We found that overexpression in MCF-7 cells results in aneuploid senescence and cell death with frequent formation of nuclear aggregates which were consistently juxtaposed to perinuclear microtubules. Transfected SRC-3 was SUMOylated and caused redistribution of nuclear promyelocytic leukemia (PML) bodies and perturbation of the nuclear membrane lamin B1, hallmarks of nucleophagy. Increased SRC-3 protein-induced autophagy and resulted in SUMO-1 localization to the nuclear membrane and formation of protrusions variously containing SRC-3 and chromatin. Aspects of SRC-3 overexpression and toxicity were recapitulated following treatment with clinically relevant agents that stabilize SRC-3 in breast cancer cells. We conclude that amplified SRC-3 levels have major impacts on nuclear protein quality control pathways and may mark cancer cells for sensitivity to protein stabilizing therapeutics.
机译:SRC-3 / AIB1(在乳腺癌1中扩增)是乳腺癌细胞中雌激素受体的核受体共激活剂。当不与转录结合伴侣结合并在转录共激活时降解时,它也是一种固有的无序蛋白。考虑到SRC-3在乳腺癌中的表达增加,本研究的目的是确定如何在MCF-7乳腺癌细胞中调节SRC-3蛋白水平的增加。我们发现内源性SRC-3是在正常生长条件下从囊状球体的细胞核中排出的,这表明SRC-3的这种核排斥形式是调节核SRC-3蛋白的体内平衡机制。从核中仅挤出与CREB结合蛋白(CBP)不相关的SRC-3。我们发现,MCF-7细胞中的过度表达会导致非整倍性衰老和细胞死亡,并频繁形成核聚集体,这些核聚集体始终与核周微管并列。转染的SRC-3被SUMO化,并引起核早幼粒细胞白血病(PML)体的重新分布和核膜层粘连蛋白B1的扰动,这是核吞噬的标志。 SRC-3蛋白诱导的自噬增加,导致SUMO-1定位于核膜并形成各种包含SRC-3和染色质的突起。在用临床相关药物稳定乳腺癌细胞中SRC-3的治疗后,概括了SRC-3过表达和毒性的方面。我们得出的结论是,扩增的SRC-3水平对核蛋白质量控制途径有重大影响,并可能标志着癌细胞对蛋白稳定疗法的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号